Rapid Acting Antidepressants in Chronic Stress Models: Molecular and Cellular Mechanisms
Stress-associated disorders, including depression and anxiety, impact nearly 20% of individuals in the United States. The social, health, and economic burden imposed by stress-associated disorders requires in depth research efforts to identify suitable treatment strategies. Traditional medications (...
Main Authors: | Brendan D. Hare, Sriparna Ghosal, Ronald S. Duman |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-04-01
|
Series: | Chronic Stress |
Online Access: | https://doi.org/10.1177/2470547017697317 |
Similar Items
-
A Medial Prefrontal Cortex Cell Type Necessary and Sufficient for a Rapid Antidepressant Response
by: Brendan D. Hare, et al.
Published: (2019-04-01) -
Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants
by: Tao Chen, et al.
Published: (2023-08-01) -
Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide [version 1; referees: 3 approved]
by: Ronald S. Duman
Published: (2018-05-01) -
Ketamine rapidly reverses stress-induced impairments in GABAergic transmission in the prefrontal cortex in male rodents
by: Sriparna Ghosal, et al.
Published: (2020-02-01) -
Molecular and cellular mechanisms of antidepressant action.
by: Sharp, T
Published: (2013)